Antimicrobial activity of the ethanolic extract of Bryonopsis laciniosa leaf, stem, fruit and seed

African Journal of Biotechnology

Volumn 8, Issue 15, 2009, Pages 3565-3567

  Ehsan, Bonyadi Rad ^a   Vital, Awad ^a   Bipinraj, Nirichan Kunchiraman ^a  

^a Bharati Vidyapeeth Deemed University   (India)

Author keywords

Antimicrobial activity; Bryonopsis laciniosa; Ethanol extract; Medicinal plant

Indexed keywords

ANTIINFECTIVE AGENT; BRYONOPSIS LACINIOSA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS; BACILLUS CERUES; BRYONOPSIS LACINIOSA; CONTROLLED STUDY; ESCHERICHIA COLI; FRUIT; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANT LEAF; PLANT STEM; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; SEED; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); BRYONOPSIS LACINIOSA; MICROCOCCUS LUTEUS; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 68949164497     PISSN: None     EISSN: 16845315     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ahmad I, Mehmood Z, Mohammad F (1998). Screening of some Indian medicinal plants for their antimicrobial properties. J. Ethnopharmacol. 62: 183-193. (Pubitemid 28400990)
2. Clark AM, Hufford CD (1993). Discco and development of novel prototype antibiotics for opportunistic infections related to the acquired immunodeficiency syndrome. In Human Medical Agents from Plants, American Chemical Society (ACS Symposium series 534), Washington, D.C. (no.534) pp. 228-241.
3. Cohen ML (1992). Epidemiology of drug resistance: implications for a post-antimicrobialera. Sci. 257: 1050-1055.
4. Cowan MM (1999). Plant Products as Antimicrobical Agents. Clin. Microbiol. Rev. 12: 564-582.
5. De Paiva SR, Figueiredo MR, Aragao TV, Kaplan MA (2003). Antimicrobial activity in vitro of plumbagin isolated from Plumbago species. Mem. Inst. Oswaldo. Cruz. 98: 959-961
6. Gupta M, Sivakumar T, Mazumdar UK, Vamsi ML, Karki SS, Sambathkumar R, Manikandan L (2003). Evaluation of anti-inflammatory activity of chloroform extract of Bryonia laciniosa in experimental animal models. Biol. Pharm. Bull. 26(9): 1342-1344.
7. Joy PP, Thomas J, Mathew S, Skaria BP (1998). In Bose TK et al. (eds) Medicinal Plants. Naya Prokash publishers, Calcutta, Trop. Horticult. 2: 449-632.
8. Kone WM, Atindehou KK, Terreaux C, Hostettmann K, Traore D, Dosso M (2004). Traditional medicine in North Cote-d'Ivoire: screening of 50 medicinal plants for antibacterial activity. J. Ethnopharmacol. 93: 43-49. (Pubitemid 38739268)
9. Mohan T (2004). pharmacological screening of some medicinal plant as antimicrobial and feed additives. M.Sc dissertation, University of Virginia, Virginia, USA.
10. Principe P (1991). Monetising the pharmacological benefits of plants. US Environmental protection Agency, Washington, D.C.
11. Sivakumar T, Perumal P, Kumar RS, Vamsi ML, Gomathi P, Mazumder UK, Gupta M (2004). Evaluation of analgesic, antipyretic activity and toxicity study of Bryonia laciniosa in mice and rats. Am. J. Chin. Med. 32(4): 531-539.